AbstractPan-drug resistant Gram-negative bacteria, being resistant to most available antibiotics, represent a huge threat to the medical community. Colistin is considered the last therapeutic option for patients in hospital settings. Thus, we were concerned in this study to demonstrate the membrane permeabilizing activity of colistin focusing on investigating its efficiency toward those pan-drug resistant isolates which represent a critical situation. We determined the killing dynamics of colistin against pan-drug resistant isolates. The permeability alteration was confirmed by different techniques as: leakage, electron microscopy and construction of an artificial membrane model; liposomes. Moreover, selectivity of colistin against microbia...
Colistin is an effective antibiotic for treatment of most multidrug-resistant Gram-negative bacteria...
Colistin (polymyxin E) is a membrane-destabilizing antibiotic used against Gram-negative bacteria. W...
Whilst colistin (polymyxin E) represents the last mainstream treatment option for multi-drug resista...
AbstractPan-drug resistant Gram-negative bacteria, being resistant to most available antibiotics, re...
Objective: Despite its use was abandoned several decades ago, the polycationic peptide colistin has ...
Colistin is an old antibiotic which has been used as a therapeutic option for carbapenem- and multid...
Colistin is increasingly used as a last resort drug to treat infections with multidrug resistant Gra...
Colistin, a cationic amphipathic polymyxin antibiotic, has been revived as a last-line therapy for G...
Colistin (polymyxin E) is a positively charged deca-peptide antibiotic that disrupts the integrity o...
AbstractColistin has been re-introduced into clinical practice for the treatment of carbapenem-resis...
Colistin is an antibiotic of last resort, but has poor efficacy and resistance is a growing problem....
The rapid rise in the prevalence of pathogenic bacteria that are resistant to front-line antibiotic ...
Recently, plasmid-mediated and, therefore, transferable bacterial polymyxin resistance was discover...
Emergence of resistant strain to antimicrobials is a growing problem worldwide. Here, we report a ca...
Colistin regained global interest as a consequence of the rising prevalence of multidrug-resistant G...
Colistin is an effective antibiotic for treatment of most multidrug-resistant Gram-negative bacteria...
Colistin (polymyxin E) is a membrane-destabilizing antibiotic used against Gram-negative bacteria. W...
Whilst colistin (polymyxin E) represents the last mainstream treatment option for multi-drug resista...
AbstractPan-drug resistant Gram-negative bacteria, being resistant to most available antibiotics, re...
Objective: Despite its use was abandoned several decades ago, the polycationic peptide colistin has ...
Colistin is an old antibiotic which has been used as a therapeutic option for carbapenem- and multid...
Colistin is increasingly used as a last resort drug to treat infections with multidrug resistant Gra...
Colistin, a cationic amphipathic polymyxin antibiotic, has been revived as a last-line therapy for G...
Colistin (polymyxin E) is a positively charged deca-peptide antibiotic that disrupts the integrity o...
AbstractColistin has been re-introduced into clinical practice for the treatment of carbapenem-resis...
Colistin is an antibiotic of last resort, but has poor efficacy and resistance is a growing problem....
The rapid rise in the prevalence of pathogenic bacteria that are resistant to front-line antibiotic ...
Recently, plasmid-mediated and, therefore, transferable bacterial polymyxin resistance was discover...
Emergence of resistant strain to antimicrobials is a growing problem worldwide. Here, we report a ca...
Colistin regained global interest as a consequence of the rising prevalence of multidrug-resistant G...
Colistin is an effective antibiotic for treatment of most multidrug-resistant Gram-negative bacteria...
Colistin (polymyxin E) is a membrane-destabilizing antibiotic used against Gram-negative bacteria. W...
Whilst colistin (polymyxin E) represents the last mainstream treatment option for multi-drug resista...